Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 444,796 | 344,407 | 211,885 | 494,151 | 496,893 |
| Marketable Securities | 1,323,307 | 1,538,763 | 1,603,433 | 1,401,824 | 1,568,446 |
| Receivables | 70,000 | N/A | N/A | 49 | 66 |
| TOTAL | $1,859,572 | $1,907,966 | $1,853,026 | $1,932,703 | $2,107,056 |
| Non-Current Assets | |||||
| PPE Net | 159,172 | 162,198 | 163,634 | 166,110 | 165,194 |
| Investments And Advances | 4,901 | 6,320 | 53,130 | 77,147 | 8,392 |
| Intangibles | 43 | 57 | 71 | 84 | 98 |
| Other Non-Current Assets | 173,326 | 167,823 | 173,196 | 177,312 | 182,623 |
| TOTAL | $337,442 | $336,398 | $390,031 | $420,653 | $356,307 |
| Total Assets | $2,197,014 | $2,244,364 | $2,243,057 | $2,353,356 | $2,463,363 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27,588 | 45,153 | 27,428 | 32,114 | 25,244 |
| Accrued Expenses | 90,396 | 85,904 | 77,817 | 107,226 | 86,176 |
| Other current liabilities | 20 | 20 | 20 | 270 | 270 |
| TOTAL | $132,837 | $146,794 | $121,107 | $150,870 | $119,957 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 235,826 | 230,351 | 234,148 | 236,209 | 240,252 |
| TOTAL | $248,149 | $242,674 | $246,471 | $248,532 | $252,575 |
| Total Liabilities | $380,986 | $389,468 | $367,578 | $399,402 | $372,532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,411 | 78,935 | 78,647 | 78,294 | 78,009 |
| Common Shares | 2,474 | 2,452 | 2,441 | 2,433 | 2,420 |
| Retained earnings | -976,895 | -899,155 | -846,090 | -735,515 | -560,966 |
| Other shareholders' equity | -8,971 | -9,451 | -15,710 | -22,325 | -20,405 |
| TOTAL | $1,816,028 | $1,854,896 | $1,875,479 | $1,953,954 | $2,090,831 |
| Total Liabilities And Equity | $2,197,014 | $2,244,364 | $2,243,057 | $2,353,356 | $2,463,363 |